vs
Side-by-side financial comparison of HALOZYME THERAPEUTICS, INC. (HALO) and Revolve Group, Inc. (RVLV). Click either name above to swap in a different company.
HALOZYME THERAPEUTICS, INC. is the larger business by last-quarter revenue ($451.8M vs $324.4M, roughly 1.4× Revolve Group, Inc.). Revolve Group, Inc. runs the higher net margin — 5.7% vs -31.3%, a 37.1% gap on every dollar of revenue. On growth, HALOZYME THERAPEUTICS, INC. posted the faster year-over-year revenue change (51.6% vs 10.4%). HALOZYME THERAPEUTICS, INC. produced more free cash flow last quarter ($217.6M vs $-13.3M). Over the past eight quarters, HALOZYME THERAPEUTICS, INC.'s revenue compounded faster (51.9% CAGR vs 9.5%).
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
Revolve Theatre Company is a Henley-on-Thames based theatre company specialising in political and Shakespearean plays. The company is owned by Oliver Dench, Joe Morris and Tom Smith.
HALO vs RVLV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $451.8M | $324.4M |
| Net Profit | $-141.6M | $18.6M |
| Gross Margin | 82.6% | 53.3% |
| Operating Margin | -20.6% | 6.3% |
| Net Margin | -31.3% | 5.7% |
| Revenue YoY | 51.6% | 10.4% |
| Net Profit YoY | -203.3% | 50.4% |
| EPS (diluted) | $-1.13 | $0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $451.8M | $324.4M | ||
| Q3 25 | $354.3M | $295.6M | ||
| Q2 25 | $325.7M | $309.0M | ||
| Q1 25 | $264.9M | $296.7M | ||
| Q4 24 | $298.0M | $293.7M | ||
| Q3 24 | $290.1M | $283.1M | ||
| Q2 24 | $231.4M | $282.5M | ||
| Q1 24 | $195.9M | $270.6M |
| Q4 25 | $-141.6M | $18.6M | ||
| Q3 25 | $175.2M | $21.2M | ||
| Q2 25 | $165.2M | $10.2M | ||
| Q1 25 | $118.1M | $11.8M | ||
| Q4 24 | $137.0M | $12.3M | ||
| Q3 24 | $137.0M | $11.0M | ||
| Q2 24 | $93.2M | $15.4M | ||
| Q1 24 | $76.8M | $10.9M |
| Q4 25 | 82.6% | 53.3% | ||
| Q3 25 | 84.4% | 54.6% | ||
| Q2 25 | 85.8% | 54.1% | ||
| Q1 25 | 81.7% | 52.0% | ||
| Q4 24 | 85.9% | 52.5% | ||
| Q3 24 | 83.0% | 51.2% | ||
| Q2 24 | 82.9% | 54.0% | ||
| Q1 24 | 85.5% | 52.3% |
| Q4 25 | -20.6% | 6.3% | ||
| Q3 25 | 61.5% | 7.1% | ||
| Q2 25 | 62.2% | 5.8% | ||
| Q1 25 | 53.4% | 5.0% | ||
| Q4 24 | 58.9% | 3.9% | ||
| Q3 24 | 56.3% | 5.0% | ||
| Q2 24 | 50.7% | 5.8% | ||
| Q1 24 | 48.8% | 3.4% |
| Q4 25 | -31.3% | 5.7% | ||
| Q3 25 | 49.5% | 7.2% | ||
| Q2 25 | 50.7% | 3.3% | ||
| Q1 25 | 44.6% | 4.0% | ||
| Q4 24 | 46.0% | 4.2% | ||
| Q3 24 | 47.2% | 3.9% | ||
| Q2 24 | 40.3% | 5.4% | ||
| Q1 24 | 39.2% | 4.0% |
| Q4 25 | $-1.13 | $0.27 | ||
| Q3 25 | $1.43 | $0.29 | ||
| Q2 25 | $1.33 | $0.14 | ||
| Q1 25 | $0.93 | $0.16 | ||
| Q4 24 | $1.06 | $0.18 | ||
| Q3 24 | $1.05 | $0.15 | ||
| Q2 24 | $0.72 | $0.21 | ||
| Q1 24 | $0.60 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $133.8M | $292.3M |
| Total DebtLower is stronger | $2.1B | — |
| Stockholders' EquityBook value | $48.8M | $512.5M |
| Total Assets | $2.5B | $765.0M |
| Debt / EquityLower = less leverage | 43.89× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $133.8M | $292.3M | ||
| Q3 25 | $419.7M | $315.4M | ||
| Q2 25 | $61.9M | $310.7M | ||
| Q1 25 | $176.3M | $300.8M | ||
| Q4 24 | $115.8M | $256.6M | ||
| Q3 24 | $154.3M | $252.8M | ||
| Q2 24 | $187.9M | $244.7M | ||
| Q1 24 | $164.6M | $273.4M |
| Q4 25 | $2.1B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.5B | — | ||
| Q1 24 | $1.5B | — |
| Q4 25 | $48.8M | $512.5M | ||
| Q3 25 | $503.9M | $490.2M | ||
| Q2 25 | $332.7M | $468.6M | ||
| Q1 25 | $482.3M | $453.4M | ||
| Q4 24 | $363.8M | $437.8M | ||
| Q3 24 | $452.7M | $420.8M | ||
| Q2 24 | $289.4M | $405.8M | ||
| Q1 24 | $177.8M | $389.9M |
| Q4 25 | $2.5B | $765.0M | ||
| Q3 25 | $2.2B | $751.3M | ||
| Q2 25 | $2.1B | $722.9M | ||
| Q1 25 | $2.2B | $713.9M | ||
| Q4 24 | $2.1B | $665.5M | ||
| Q3 24 | $2.1B | $670.9M | ||
| Q2 24 | $2.0B | $657.8M | ||
| Q1 24 | $1.8B | $650.0M |
| Q4 25 | 43.89× | — | ||
| Q3 25 | 3.00× | — | ||
| Q2 25 | 4.54× | — | ||
| Q1 25 | 3.13× | — | ||
| Q4 24 | 4.14× | — | ||
| Q3 24 | 3.32× | — | ||
| Q2 24 | 5.19× | — | ||
| Q1 24 | 8.44× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $219.0M | $-10.2M |
| Free Cash FlowOCF − Capex | $217.6M | $-13.3M |
| FCF MarginFCF / Revenue | 48.2% | -4.1% |
| Capex IntensityCapex / Revenue | 0.3% | 1.0% |
| Cash ConversionOCF / Net Profit | — | -0.55× |
| TTM Free Cash FlowTrailing 4 quarters | $644.6M | $48.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $219.0M | $-10.2M | ||
| Q3 25 | $178.6M | $11.8M | ||
| Q2 25 | $99.7M | $12.6M | ||
| Q1 25 | $154.2M | $45.1M | ||
| Q4 24 | $178.5M | $3.9M | ||
| Q3 24 | $115.4M | $9.1M | ||
| Q2 24 | $55.8M | $-24.7M | ||
| Q1 24 | $129.4M | $38.4M |
| Q4 25 | $217.6M | $-13.3M | ||
| Q3 25 | $175.6M | $7.5M | ||
| Q2 25 | $98.1M | $10.4M | ||
| Q1 25 | $153.3M | $43.4M | ||
| Q4 24 | $175.4M | $2.1M | ||
| Q3 24 | $113.9M | $8.0M | ||
| Q2 24 | $53.2M | $-25.7M | ||
| Q1 24 | $125.9M | $36.7M |
| Q4 25 | 48.2% | -4.1% | ||
| Q3 25 | 49.6% | 2.5% | ||
| Q2 25 | 30.1% | 3.4% | ||
| Q1 25 | 57.9% | 14.6% | ||
| Q4 24 | 58.9% | 0.7% | ||
| Q3 24 | 39.3% | 2.8% | ||
| Q2 24 | 23.0% | -9.1% | ||
| Q1 24 | 64.3% | 13.5% |
| Q4 25 | 0.3% | 1.0% | ||
| Q3 25 | 0.9% | 1.5% | ||
| Q2 25 | 0.5% | 0.7% | ||
| Q1 25 | 0.4% | 0.6% | ||
| Q4 24 | 1.0% | 0.6% | ||
| Q3 24 | 0.5% | 0.4% | ||
| Q2 24 | 1.1% | 0.4% | ||
| Q1 24 | 1.8% | 0.6% |
| Q4 25 | — | -0.55× | ||
| Q3 25 | 1.02× | 0.56× | ||
| Q2 25 | 0.60× | 1.24× | ||
| Q1 25 | 1.31× | 3.82× | ||
| Q4 24 | 1.30× | 0.32× | ||
| Q3 24 | 0.84× | 0.83× | ||
| Q2 24 | 0.60× | -1.60× | ||
| Q1 24 | 1.68× | 3.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HALO
| Royalty | $258.0M | 57% |
| Products | $122.7M | 27% |
| Proprietary Products Sales | $59.6M | 13% |
| Device Partnered Products | $12.9M | 3% |
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
